大環內酯類抗生素在支氣管擴張癥中的應用_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

曾軍

Corresponding?author：

Keywords：

大環內酯; 抗生素; 支氣管擴張癥

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 曾軍. 大環內酯類抗生素在支氣管擴張癥中的應用. Chinese Journal of Respiratory and Critical Care Medicine, 2007, 6(3): 166-168. doi: Copy

1.	Amsden GW. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother.2005，55：10-21.
2.	Tsang KW，Ho PI，Chan KN，et al. A pilot study of low-dose erythromycin in bronchiectasis.Eur Respir J. 1999 Feb;13(2):361-4..
3.	Koh YY, Lee MH, Sun YH,et al. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.Eur Respir J. 1997 May;10(5):994-9.
4.	Yalcin E，Kiper N，Ozcelik U，et al. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.J Clin Pharm Ther. 2006 Feb;31(1):49-55.
5.	Tagaya E，Tamaoki J，Kondo M，et al. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.Chest. 2002 Jul;122(1):213-8.
6.	Cymbala AA，Edmonds LC，Bauer MA，et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis.Treat Respir Med. 2005;4(2):117-22.
7.	Davies G，Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin.Thorax. 2004 Jun;59(6):540-1.
8.	Black PN. Anti-inflammatory effects of macrolide antibiotics.Eur Respir J. 1997 May;10(5):971-2.
9.	Konno S，Adachi M，Asano K，et al. Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes. Life Sci，1993，52：PL25–30.
10.	Tamaoki J，Tagaya E，Sakai A，et al. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol，1995，95：853–859.
11.	Rubin BK，Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest，2004，125：70S-78S.
12.	Molinari G, Guzman CA, Pesce A,et al. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.J Antimicrob Chemother. 1993 May;31(5):681-8.
13.	Vranes J.. Effect of subminimal inhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to polystyrene.J Chemother. 2000 Aug;12(4):280-5.
14.	Bui，K.Q，Banevicius，M.A，Nightingale，C.H.et al.IIn vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.J Antimicrob Chemother. 2000 Jan;45(1):57-62.
15.	Tamaoki，J，Takeyama，K，Tagaya，E，et al. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother. 1995 Aug;39(8):1688-90.

1. Amsden GW. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother.2005，55：10-21.
2. Tsang KW，Ho PI，Chan KN，et al. A pilot study of low-dose erythromycin in bronchiectasis.Eur Respir J. 1999 Feb;13(2):361-4..
3. Koh YY, Lee MH, Sun YH,et al. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.Eur Respir J. 1997 May;10(5):994-9.
4. Yalcin E，Kiper N，Ozcelik U，et al. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.J Clin Pharm Ther. 2006 Feb;31(1):49-55.
5. Tagaya E，Tamaoki J，Kondo M，et al. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.Chest. 2002 Jul;122(1):213-8.
6. Cymbala AA，Edmonds LC，Bauer MA，et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis.Treat Respir Med. 2005;4(2):117-22.
7. Davies G，Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin.Thorax. 2004 Jun;59(6):540-1.
8. Black PN. Anti-inflammatory effects of macrolide antibiotics.Eur Respir J. 1997 May;10(5):971-2.
9. Konno S，Adachi M，Asano K，et al. Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes. Life Sci，1993，52：PL25–30.
10. Tamaoki J，Tagaya E，Sakai A，et al. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol，1995，95：853–859.
11. Rubin BK，Henke MO. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest，2004，125：70S-78S.
12. Molinari G, Guzman CA, Pesce A,et al. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.J Antimicrob Chemother. 1993 May;31(5):681-8.
13. Vranes J.. Effect of subminimal inhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to polystyrene.J Chemother. 2000 Aug;12(4):280-5.
14. Bui，K.Q，Banevicius，M.A，Nightingale，C.H.et al.IIn vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.J Antimicrob Chemother. 2000 Jan;45(1):57-62.
15. Tamaoki，J，Takeyama，K，Tagaya，E，et al. Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother. 1995 Aug;39(8):1688-90.

Chinese Journal of Respiratory and Critical Care Medicine

大環內酯類抗生素在支氣管擴張癥中的應用

Abstract Full text Figures/Tables Video References Cited by

Format

Content